In this episode, Eric Hamon, President and CEO of Driscoll Children’s Hospital, discusses how Driscoll Children’s is increasing access to pediatric care through new facilities, specialist recruitment, and an innovative fleet of planes that brings care directly to children across…
The Latest
In this episode, Dr. Osamah Choudhry, Co Founder and CEO of Medivis and neurosurgeon at NYU Langone Health, discusses the evolving role of artificial intelligence and augmented reality in spine and cranial surgery. He shares insights on FDA clearances, distribution…
In this episode, Dr. Osamah Choudhry, Co Founder and CEO of Medivis and neurosurgeon at NYU Langone Health, discusses the evolving role of artificial intelligence and augmented reality in spine and cranial surgery. He shares insights on FDA clearances, distribution…
In this episode, Scott Hawig, Executive Vice President and CFO of BJC Health, shares how the $12 billion, 14 hospital system is strengthening access across the Midwest following its rebrand and merger with St. Luke’s Health System. He discusses rising…
In this episode, Dr. Justin Dunn, Interventional Cardiologist and Regional Director of the Valve and Structural Heart Disease Center at University Hospitals Harrington Heart & Vascular Institute at UH Lake West Medical Center, discusses expanding complex cardiac procedures into community…
In this episode, Dr. Mayank K. Shah, Vice President and Chief Medical Officer of Advocate Condell Medical Center, part of Advocate Aurora Health, shares how his team elevated safety and quality to top Leapfrog grades, advanced AI adoption, and is…
In this episode, Saria Saccocio, MD, MHA, Chief Medical Officer of Essence Healthcare, discusses the growing collaboration between payers and providers, the push for site neutral care and pharmacy cost reform, and the need for stronger investment in cardiometabolic and…
In this episode, Gina Cronin, FACHE, Executive Vice President and Chief People Officer at Children’s National Hospital, discusses aligning leaders around a new five year strategy, redesigning roles amid major ERP and EHR transformations, and building resilient workforce capabilities and…
The FDA has classified Boston Scientific’s removal of certain Axios Stent and Electrocautery-Enhanced Delivery Systems as a Class I recall, the agency’s most serious designation. The recall stems from increased reports of deployment and expansion issues during stent placement. As…
Over the next three to five years, the chief pharmacy officer role is expected to expand well beyond operational oversight. Dispensing excellence and medication safety will remain foundational. But what will distinguish successful leaders in 2026 and beyond is enterprise-level…